Retrovirus Genome Differences

Retroviruses are a family of RNA viruses that replicate by using a reverse transcriptase enzyme to produce DNA from their RNA genome. This DNA is then integrated into the host cell's genome.

Retroviruses can be classified based on how they cause disease, particularly cancer. Two important types are slow-acting retroviruses and transducing retroviruses.

Transducing Retrovirus Genome

Transducing retroviruses are known for their ability to cause tumors rapidly. This is because their genome typically includes a viral oncogene (v-onc). This oncogene is often acquired from a cellular proto-oncogene (c-onc) through a process involving recombination during replication. Once integrated into the host cell, the viral oncogene is expressed, leading to uncontrolled cell growth and tumor formation.

Slow-acting Retrovirus Genome

Slow-acting retroviruses, unlike transducing retroviruses, generally do not carry their own oncogene in their genome. Their mechanism for causing cancer is different and takes longer (hence "slow-acting"). They integrate their proviral DNA into the host cell's genome. If the integration site is near a cellular proto-oncogene, the strong viral regulatory elements (like promoters and enhancers, typically found in the viral LTRs or Long Terminal Repeats) can cause overexpression or abnormal expression of the cellular proto-oncogene. This deregulation of the proto-oncogene can then lead to cell transformation and cancer.

Genome Comparison: Slow-acting vs. Transducing

The fundamental difference in the genome between slow-acting retroviruses and transducing retroviruses lies in the presence or absence of an oncogene.

• Transducing retroviruses: Genome includes a viral oncogene (v-onc).
• Slow-acting retroviruses: Genome lacks a viral oncogene (v-onc).

While slow-acting retroviruses can cause cancer by affecting nearby cellular proto-oncogenes after integration, their inherent genome structure is characterized by the absence of a dedicated viral oncogene.

Analyzing the Options

Let's look at the given options based on this understanding:

1. They cannot activate nearby cellular proto-oncogenes after integration into the genome of the host cell

   This is incorrect. Slow-acting retroviruses *do* cause cancer precisely by activating nearby cellular proto-oncogenes through insertional mutagenesis.

2. They lack an oncogene

   This is correct. Slow-acting retroviruses are defined by the absence of a viral oncogene in their genome, which is the key difference from transducing retroviruses.

3. They exclude mouse mammary tumor viruses

   This is incorrect. Mouse mammary tumor virus (MMTV) is a classic example of a slow-acting retrovirus that causes tumors by integrating near and activating cellular proto-oncogenes like Wnt-1.

4. They have acquired mutations during acquisition of an oncogene

   This statement better describes the origin of the oncogenes found in *transducing* retroviruses (derived from cellular genes through recombination/mutation), not a characteristic difference of slow-acting viruses.

Therefore, the primary difference in the genome of slow-acting retroviruses compared to transducing viruses is that slow-acting viruses lack an oncogene.